Literature DB >> 11388523

Tissue injury and the inflammatory response to pediatric cardiac surgery with cardiopulmonary bypass: a descriptive study.

M S Chew1, I Brandslund, V Brix-Christensen, H B Ravn, V E Hjortdal, J Pedersen, K Hjortdal, O K Hansen, E Tønnesen.   

Abstract

BACKGROUND: There are few detailed descriptions of the inflammatory response to cardiac surgery with cardiopulmonary bypass (CPB) in children beyond 24 h postoperatively. This is especially true for the antiinflammatory cytokines and the extent of tissue injury. The aim of the current study was to describe the inflammatory and injury responses in uncomplicated pediatric cardiac surgery with CPB, where methylprednisolone and modified ultrafiltration (MUF) were used.
METHODS: Blood samples were collected up to 48 h postoperatively. Cytokines (tumor necrosis factor-alpha and interleukin-6, -1beta, -10, and -1ra), complement (C3d and C4d) and coagulation system (prothrombin activation fragments 1 and 2 and antithrombin III) activation, neutrophil elastase, and the resulting tissue injury (creatine kinase, lactate dehydrogenase, alanine transaminase, amylase, and gamma-glutamyl transferase) were measured.
RESULTS: The proinflammatory cytokine release varied widely, in contrast to a clear-cut antiinflammatory response. Cytokine concentrations did not decrease immediately after MUF, and no rebound increases later in the postoperative period were observed. The coagulation system, but not complement, was activated. There was a late release of C-reactive protein. Tissue injury could be quantified biochemically without evidence of hepatic or pancreatic dysfunction.
CONCLUSION: In this group of uncomplicated subjects, the antiinflammatory cytokine and tissue injury responses were well defined, in contrast to a variable proinflammatory cytokine release. This was accompanied by activation of the coagulation system but not of complement. Concentrations of inflammatory mediators did not decrease immediately after MUF, and there was no evidence for rebound release later in the postoperative period.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11388523     DOI: 10.1097/00000542-200105000-00010

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  27 in total

1.  Angiotensin-converting enzyme inhibition alters the inflammatory and fibrinolytic response to cardiopulmonary bypass in children.

Authors:  Gregory A Fleming; Frederic T Billings; Tom M Klein; David P Bichell; Karla G Christian; Mias Pretorius
Journal:  Pediatr Crit Care Med       Date:  2011-09       Impact factor: 3.624

Review 2.  WITHDRAWN: Prophylactic steroids for pediatric open heart surgery.

Authors:  Mahmoud Elbarbary; Wedad H Madani; Suzanne Robertson-Malt
Journal:  Cochrane Database Syst Rev       Date:  2015-10-21

3.  Interleukin-6 and interleukin-10 as acute kidney injury biomarkers in pediatric cardiac surgery.

Authors:  Jason H Greenberg; Richard Whitlock; William R Zhang; Heather R Thiessen-Philbrook; Michael Zappitelli; Prasad Devarajan; John Eikelboom; Peter A Kavsak; P J Devereaux; Colleen Shortt; Amit X Garg; Chirag R Parikh
Journal:  Pediatr Nephrol       Date:  2015-04-15       Impact factor: 3.714

4.  Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome.

Authors:  R Arkader; E J Troster; M R Lopes; R R Júnior; J A Carcillo; C Leone; T S Okay
Journal:  Arch Dis Child       Date:  2005-12-02       Impact factor: 3.791

5.  Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study.

Authors:  R K Kharbanda; J Li; I E Konstantinov; M M H Cheung; P A White; H Frndova; J Stokoe; P Cox; M Vogel; G Van Arsdell; R MacAllister; A N Redington
Journal:  Heart       Date:  2006-07-03       Impact factor: 5.994

Review 6.  Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery.

Authors:  Colleen E Gruenwald; Cedric Manlhiot; Lynn Crawford-Lean; Celeste Foreman; Leonardo R Brandão; Brian W McCrindle; Helen Holtby; Ross Richards; Helen Moriarty; Glen Van Arsdell; Anthony K Chan
Journal:  J Extra Corpor Technol       Date:  2010-03

Review 7.  Extracorporeal membrane oxygenation and cytokine adsorption.

Authors:  Thomas Datzmann; Karl Träger
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

8.  Peri-operative interventions, but not inflammatory mediators, increase risk of acute kidney injury after cardiac surgery: a prospective cohort study.

Authors:  Catherine J Morgan; Peter J Gill; Simon Lam; Ari R Joffe
Journal:  Intensive Care Med       Date:  2013-02-16       Impact factor: 17.440

9.  The Association between Cytokines and 365-Day Readmission or Mortality in Adult Cardiac Surgery.

Authors:  Allen D Everett; Shama S Alam; Sherry L Owens; Devin M Parker; Christine Goodrich; Donald S Likosky; Heather Thiessen-Philbrook; Moritz Wyler von Ballmoos; Kevin Lobdell; Todd A MacKenzie; Jeffrey Jacobs; Chirag R Parikh; Anthony W DiScipio; David J Malenka; Jeremiah R Brown
Journal:  J Extra Corpor Technol       Date:  2019-12

10.  Continuous monitoring of inflammation biomarkers during simulated cardiopulmonary bypass using a microfluidic immunoassay device - a pilot study.

Authors:  Lawrence A Sasso; Kiana Aran; Yulong Guan; Akif Ündar; Jeffrey D Zahn
Journal:  Artif Organs       Date:  2013-01       Impact factor: 3.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.